Identification of a Stable, Non-Canonically Regulated Nrf2 Form in Lung Cancer Cells

Area of Science:

• Molecular Biology
• Cellular Stress Response
• Cancer Biology

Background:

• Nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) is a transcription factor crucial for cell survival against various stresses.
• Nrf2 regulates key cellular processes including proliferation, metabolism, and apoptosis, and is implicated in chronic diseases.
• Dysregulated Nrf2 activity, often due to mutations or oncogene activation, promotes cancer progression and treatment resistance.

Purpose of the Study:

• To elucidate the mechanism behind basal Nrf2 target gene expression under homeostatic (non-stress) conditions.
• To identify novel Nrf2 forms contributing to its constitutive activity.

Main Methods:

• Identification and characterization of a stable Nrf2 protein form.
• Analysis of Nrf2 translocation to the nucleus in lung cancer cells.
• RNA-Sequencing (RNA-Seq) to investigate the origin of Nrf2 transcripts.

Main Results:

• A stable 105 kDa Nrf2 protein form, resistant to Keap1-Cullin 3 (Cul3)-mediated degradation, was identified.
• This stable Nrf2 form was observed to translocate into the nucleus of lung cancer cells.
• RNA-Seq data suggested that this stable form may arise from exon 2 or exon 3-truncated Nrf2 transcripts.

Conclusions:

• The stable 105 kDa Nrf2 form likely contributes to the constitutive activation of Nrf2 target genes under normal cellular conditions.
• This finding provides a potential explanation for basal Nrf2 activity, independent of external stress.
• Understanding this mechanism could offer new therapeutic strategies for diseases involving Nrf2 dysregulation.